Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-431-5 | CAS number: 470-82-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral: A key study was not available on the target substance therefore data was presented on the read across substance, Clarycet. The acute median lethal oral dose for males and females combined were 4.5 g/kg body weight; for males only it was estimated to be 4.7 g/kg body weight (and for females only was 4.3 g/kg body weight
Acute dermal: A key study was not available on the target substance therefore data was presented on the read across substance, Clarycet. The LD50 of Clarycet was > 2.0 g/kg bodyweight; a supporting study on the target substance itself had an LD50 of 5.0 g/kg bodyweight.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 4 500 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
Acute - Oral
A key study was not available on the target substance therefore data was presented on the read across substance, Clarycet. Clarycet was assessed for acute oral toxicity in the rat according to OECD guideline 401. The acute median lethal oral dose and the 95 % confidence limit for males and females combined were 4.5 g/kg body weight (3.3 - 5.8 g/kg confidence limits); for males only it was estimated to be 4.7 g/kg body weight (3.2 - 7.0 g/kg confidence limits) and for females only was 4.3 g/kg body weight (2.8 - 6.1 g/kg confidence limits).
In a supporting study, the target substance itself was assessed for acute oral toxicity. The oral administration of Cineole to rats for 14 days produced no toxicologically significant effects in the parameters measured. The study determined that the acute oral LD₅₀ of the test material to rats was 2480 mg/kg bw.
Acute - Dermal
Key study for acute dermal in vivo (Huntingdon, 1991, OECD Guideline 402).
The dermal administration of a single exposure to the read-across substance, Clarycet, at 2 g/kg bodyweight produced no toxicologically significant results. The acute dermal LD50 was therefore > 2 g/kg bodyweight.
To address toxicological endpoints as part of the REACH registration of Cineole (Target Substance) it is proposed to read-across to Clarycet (Source Substance).
The use of read-across works within the spirit of REACH and the stated aim of the legislation to reduce animal testing where possible.
The Target Substance and Source Substance have been characterised in using the categories and databases present in the OECD (Q)SAR Toolbox. From the profiling in this table, it can be seen that the two substances share structural similarities and also "mechanistic action" similarities which are both general and endpoint specific.
Therefore read-across is justified.
Justification for selection of acute toxicity – inhalation endpoint
The oral and dermal LD50 levels for the test substance have been determined and both demonstrate relatively harmless levels of acute toxicity >2000 mg/kg bw, with the acute oral LD50 of > 4500 mg/kg and therefore do not require labelling under CLP. Testing by the inhalation route in accordance with column 2 of Annex VIII of 1907/2006/EC, is therefore considered to be inappropriate as exposure of humans via inhalation is unlikely taking into account the vapour pressure of the substance (122 Pa at 25°C) and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size.
Justification for classification or non-classification
Based on the oral LD50 values of >2480 mg/kg bodyweight and dermal LD50 values of > 2000 mg/kg bodyweight, there is no need to classify Cineole for acute to toxicity in accordance with the criteria outlined in Annex VI of 67/548/EEC (DSD) and Annex I of 1272/2008/EC (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.